Market Overview

Morning Market Losers

Related ATHX
What Investors Are Looking At In The Stem Cell Sector
What Investors Are Looking For In Brainstorm Cell Therapeutics' Upcoming Clinical Results
Related OGXI
US Stock Futures Slip Ahead Of Goldman Sachs Earnings
Benzinga's Top #PreMarket Gainers

Athersys (NASDAQ: ATHX) shares tumbled 55.99% to $1.20 on failed trial results for ulcerative colitis.

OncoGenex Pharmaceuticals (NASDAQ: OGXI) dipped 53.61% to $4.50 after the company and Teva Pharmaceutical Industries (NYSE: TEVA) offered top-line survival results of the Phase III SYNERGY trial for combo with first-line docetaxel/prednisone therapy.

Eltek (NASDAQ: ELTK) declined 19.87% to $1.73 after the company reported Q4 earnings of $0.39 per share on revenue of $12.70 million.

POZEN (NASDAQ: POZN) declined 15.66% to $7.70 following Friday's Complete Response Letter from the FDA.

New Oriental Education & Technology Group (NYSE: EDU) shares dropped 11.35% to $23.03 after the company reported FQ3 results. New Oriental's quarterly net income surged 50.2% y/y to US$42.1 million versus US$28.0 million. (NASDAQ: SOHU) fell 7.91% to $53.41 after the company reported a Q1 adjusted loss of $1.26 per share on revenue of $365.0 million.

Newmont Mining (NYSE: NEM) shares slipped 6.01% to $24.86 after the company terminated its merger talks with Barrick Gold (NYSE: ABX).

Bank of America (NYSE: BAC) shares slipped 4.83% to $15.18 following news from the company the Board will be suspending the previously announced capital actions and resubmit the 2014 capital plan.

Mylan (NASDAQ: MYL) tumbled 4.15% to $49.94 after Meda's board rejected Mylan proposal. (NASDAQ: CYOU) shares slipped 3.94% to $25.60 after the company reported a Q1 loss $0.37 per share on revenue of $180.80 million.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets


Related Articles (ATHX + ABX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional